Funder: ALS Association
Due Dates (Anticipated): June 8, 2026 (LOI) | August 10, 2026 (Full Proposal, by invitation)
Funding Amounts: Up to $400,000 total over 4 years (including direct and indirect costs)
Summary: Supports U.S. clinical trial sites in expanding ALS trial capacity, diversity, and efficiency, with emphasis on eliminating participation barriers for underserved populations.
Key Information: U.S. trial sites only; applications expected to open annually—currently not accepting new proposals.